Evidence map›Paper›PMID 39285331›Full record

ArticleBMC plant biology2024

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang, Xianjing Li, Niaojiao Xu, Haitao Li, Lu Qu, Yunqiang Wang, Cuiyun Yin, Lixia Zhang and 1 more

Abstract readComparative Study
In one paragraph

Article in BMC plant biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. The complete chloroplast genome and phylogenetic analysis ofMitochondrial DNA. Part B, Resources · 2026
    Article
  2. The complete chloroplast genome and phylogenetic analysis ofMitochondrial DNA. Part B, Resources · 2026
    Article
  3. Article
  4. A Recent Lineage Split inEcology and evolution · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yue ZhangYunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch of Institute of Medicinal Plant Development Chinese Academy of Medical Sciences, Peking Union Medical College, Jinghong, 666100, China.
Meifang SongYunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch of Institute of Medicinal Plant Development Chinese Academy of Medical Sciences, Peking Union Medical College, Jinghong, 666100, China.
Deying TangYunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch of Institute of Medicinal Plant Development Chinese Academy of Medical Sciences, Peking Union Medical College, Jinghong, 666100, China.
Xianjing LiCollege of Pharmacy, Dali University, Dali, 671000, China.
Niaojiao XuCollege of Pharmacy, Dali University, Dali, 671000, China.
Haitao LiYunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch of Institute of Medicinal Plant Development Chinese Academy of Medical Sciences, Peking Union Medical College, Jinghong, 666100, China.
Lu QuYunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch of Institute of Medicinal Plant Development Chinese Academy of Medical Sciences, Peking Union Medical College, Jinghong, 666100, China.
Yunqiang WangYunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch of Institute of Medicinal Plant Development Chinese Academy of Medical Sciences, Peking Union Medical College, Jinghong, 666100, China.
Cuiyun YinYunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch of Institute of Medicinal Plant Development Chinese Academy of Medical Sciences, Peking Union Medical College, Jinghong, 666100, China.
Lixia ZhangYunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch of Institute of Medicinal Plant Development Chinese Academy of Medical Sciences, Peking Union Medical College, Jinghong, 666100, China.
Zhonglian ZhangYunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch of Institute of Medicinal Plant Development Chinese Academy of Medical Sciences, Peking Union Medical College, Jinghong, 666100, China. zzl0605@163.com.

Funding

Yunnan "Xingdian Talent Support Program " young talents special project and CAMS Innovation Fund for Medical Sciences (CIFMS) 2021-I2M-1-032
6 · The paper itself

Abstract

backgroundLasianthus species are widely used in traditional Chinese folk medicine with high medicinal value. However, source materials and herbarium specimens are often misidentified due to morphological characteristics and commonly used DNA barcode fragments are not sufficient for accurately identifying Lasianthus species. To improve the molecular methods for distinguishing among Lasianthus species, we report the complete chloroplast (CP) genomes of Lasianthus attenuatus, Lasianthus henryi, Lasianthus hookeri, Lasianthus sikkimensis, obtained via high-throughput Illumina sequencing.

resultsThese showed CP genomes size of 160164-160246 bp and a typical quadripartite structure, including a large single-copy region (86675-86848 bp), a small single-copy region (17177-17326 bp), and a pair of inverted repeats (28089-28135 bp). As a whole, the gene order, GC content and IR/SC boundary structure were remarkably similar among of the four Lasianthus CP genomes, the partial gene length and IR, LSC and SSC regions length are still different. The average GC content of the CP genomes was 36.71-36.75%, and a total of 129 genes were detected, including 83 different protein-coding genes, 8 different rRNA genes and 38 different tRNA genes. Furthermore, we compared our 4 complete CP genomes data with publicly available CP genome data from six other Lasianthus species, and we initially screened eleven highly variable region fragments were initially screened. We then evaluated the identification efficiency of eleven highly variable region fragments and 5 regular barcode fragments. Ultimately, we found that the optimal combination fragment' ITS2 + psaI-ycf4' could authenticated the Lasianthus species well. Additionally, the results of genome comparison of Rubiaceae species showed that the coding region is more conservative than the non-coding region, and the ycf1 gene shows the most significant variation. Finally, 49 species of CP genome sequences belonging to 16 genera of the Rubiaceae family were used to construct phylogenetic trees.

conclusionsOur research is the first to analyze the chloroplast genomes of four species of Lasianthus in detail and we ultimately determined that the combination fragment' ITS2 + psaI-ycf4' is the optimal barcode combination for identifying the genus of Lasianthus. Meanwhile, we gathered the available CP genome sequences from the Rubiaceae and used them to construct the most comprehensive phylogenetic tree for the Rubiaceae family. These investigations provide an important reference point for further studies in the species identification, genetic diversity, and phylogenetic analyses of Rubiaceae species.

Indexed as

Genome, ChloroplastPhylogenyBase CompositionGenetic MarkersHigh-Throughput Nucleotide SequencingSequence Analysis, DNAGenetic MarkersChloroplast genomeLasianthusPhylogenetic relationshipRubiaceaeSpecies identification

Identifiers

PMID39285331
PMCPMC11406864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.